BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15711751)

  • 1. Crotalid venom vascular endothelial growth factors has preferential affinity for VEGFR-1. Characterization of Protobothrops mucrosquamatus venom VEGF.
    Chen YL; Tsai IH; Hong TM; Tsai SH
    Thromb Haemost; 2005 Feb; 93(2):331-8. PubMed ID: 15711751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1.
    Takahashi H; Hattori S; Iwamatsu A; Takizawa H; Shibuya M
    J Biol Chem; 2004 Oct; 279(44):46304-14. PubMed ID: 15328352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
    Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
    Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine papular stomatitis virus encodes a functionally distinct VEGF that binds both VEGFR-1 and VEGFR-2.
    Inder MK; Ueda N; Mercer AA; Fleming SB; Wise LM
    J Gen Virol; 2007 Mar; 88(Pt 3):781-791. PubMed ID: 17325350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parapoxvirus of red deer in New Zealand encodes a variant of viral vascular endothelial growth factor.
    Ueda N; Inder MK; Wise LM; Fleming SB; Mercer AA
    Virus Res; 2007 Mar; 124(1-2):50-8. PubMed ID: 17109982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of VEGFR-1-binding domain of VEGF-A with modelled VEGF-C sheds light on receptor specificity.
    Kasap M; Sazci A
    J Theor Biol; 2008 Aug; 253(3):446-51. PubMed ID: 18479712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
    Yamazaki Y; Tokunaga Y; Takani K; Morita T
    Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.
    Li H; Cao W; Chen Z; Acheampong DO; Jin H; Li D; Zhang J; Wang M
    Biomed Pharmacother; 2013 Sep; 67(7):599-606. PubMed ID: 23906761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling.
    Toivanen PI; Nieminen T; Laakkonen JP; Heikura T; Kaikkonen MU; Ylä-Herttuala S
    Sci Rep; 2017 Jul; 7(1):5525. PubMed ID: 28717175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.
    Heil M; Mitnacht-Krauss R; Issbrücker K; van den Heuvel J; Dehio C; Schaper W; Clauss M; Weich HA
    Angiogenesis; 2003; 6(3):201-11. PubMed ID: 15041796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific distribution of VEGF-F in Viperinae snake venoms: isolation and characterization of a VGEF-F from the venom of Daboia russelli siamensis.
    Tokunaga Y; Yamazaki Y; Morita T
    Arch Biochem Biophys; 2005 Jul; 439(2):241-7. PubMed ID: 15992764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminus of viral vascular endothelial growth factor-E partially blocks binding to VEGF receptor-1.
    Inder MK; Wise LM; Fleming SB; Mercer AA
    FEBS J; 2008 Jan; 275(1):207-17. PubMed ID: 18076652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns.
    Jeltsch M; Karpanen T; Strandin T; Aho K; Lankinen H; Alitalo K
    J Biol Chem; 2006 Apr; 281(17):12187-95. PubMed ID: 16505489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
    Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
    FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor from Trimeresurus jerdonii venom specifically binds to VEGFR-2.
    Zhong S; Wu J; Cui Y; Li R; Zhu S; Rong M; Lu Q; Lai R
    Biochimie; 2015 Sep; 116():1-7. PubMed ID: 26107411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.
    Shraga-Heled N; Kessler O; Prahst C; Kroll J; Augustin H; Neufeld G
    FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
    Lake AC; Vassy R; Di Benedetto M; Lavigne D; Le Visage C; Perret GY; Letourneur D
    J Biol Chem; 2006 Dec; 281(49):37844-52. PubMed ID: 17028197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2.
    Mohamedali KA; Ran S; Gomez-Manzano C; Ramdas L; Xu J; Kim S; Cheung LH; Hittelman WN; Zhang W; Waltenberger J; Thorpe PE; Rosenblum MG
    BMC Cancer; 2011 Aug; 11():358. PubMed ID: 21849059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants of growth factor binding and specificity by VEGF receptor 2.
    Leppänen VM; Prota AE; Jeltsch M; Anisimov A; Kalkkinen N; Strandin T; Lankinen H; Goldman A; Ballmer-Hofer K; Alitalo K
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2425-30. PubMed ID: 20145116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.